SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-009424
Filing Date
2022-03-04
Accepted
2022-03-04 17:09:34
Documents
3
Period of Report
2022-03-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5656
2 EX-24 DOCUMENT attachment1.htm EX-24 3134
3 EX-24.1 DOCUMENT attachment2.htm EX-24.1 1707
  Complete submission text file 0000899243-22-009424.txt   11985
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Issuer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SYROS PHARMACEUTICALS, INC. 620 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Simonian Nancy A (Reporting) CIK: 0001359574 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-32405 | Film No.: 22715155